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Background: Cardiac resynchronization therapy (CRT) or biventricular pacing improves survival for heart failure patients (pts), but whether this 
benefit extends to recipients of a left ventricular assist device (LVAD) is unknown. Anecdotally, biventricular pacing following LVAD surgery has been 
associated with more frequent ventricular tachy-arrhythmias (VA). We reviewed our single-center experience to determine whether CRT following LVAD 
surgery was associated with harm.
Methods: Retrospective chart review of all pts who received LVAD between January 1, 2006 and August 1, 2009 who had an implantable 
cardioverter defibrillator (ICD) alone or with CRT. We compared the rates of VA between these two groups.
Results: Of the 105 LVAD pts, 35 (29 males [83%], age 56 ± 12 years) had an LVAD plus an ICD (CRT-D in 22 pts [63%]). There were no 
differences in ejection fraction, no. pts with ischemic v. nonischemic heart disease, use of antiarrhythmic drugs, use of inotropes, duration of LVAD 
support and survival. VA occurred in 14 (64%) CRT-D pts of whom 43% received an ICD shock, 14% anti-tachycardia pacing and 64% antiarrhythmic 
drug therapy at mean 49 (median 27, IQR: 16-53) days following LVAD placement. The majority of VA (86%) occurred after the 1st post-operative 
week. By comparison, fewer ICD pts experienced VA (4, 31%, p=0.04 v. CRT-D) at mean 13 (median 6, IQR: 5-14) days following LVAD placement. Two 
pts with CRT-D had LV pacing disabled, and experienced no further VA.
Conclusions: CRT was associated with an increased occurrence of VA following LVAD placement. In the absence of proven benefit to CRT in 
LVAD pts, our results suggest that LV pacing should be disabled following LVAD placement. Further study is warranted to better elucidate the 
arrhythmogenic nature of LV pacing in this unique population. 
